High prevalence of kidney
failure due to unhealthy lifestyles has led to increased demand for kidney
function tests. According to the World Health Organization (WHO), there is
nearly 8% rise in the chronic kidney disease (CKD) cases every year. Kidney
function tests can determine the probability of CKD in diabetic and
non-diabetics at early stages.
How it Works?
Kidney or renal function
tests can determine the possibility of CKD and other kidney-related disorders.
Different types of tests such as creatinine clearance test, furosemide test,
and glomerular filtration rate (GFR or eGFR) test are used to determine
functioning of renal system. Early detection of kidney failure can prevent the
progression of such diseases. Hypertension, frequent urge to urinate, and
swelling of hands & feet are the common symptoms of kidney diseases.
Developments
Recently, the United States
Food & Drug Administration (FDA) approved marketing of a noninvasive kidney
function test. . EUROIMMUN US, Inc., a US-based company has developed this test
for membranous glomerulonephritis (MGN) diagnosis. MGN affects the glomeruli in
the kidney.
Proteomics International
Limited, an Australian life sciences company, launched a prognostic test to
determine the possibility of diabetic kidney disease (DKD). This blood sample
test identifies at-risk groups and recommends treatment options to prevent
prognosis of the disease.
Market Overview
The worldwide kidney function
tests market is projected at nearly USD 2 billion by
2025, according to Grand View Research, Inc. It is anticipated to grow at a
5.2% CAGR over the forecast period (2014 to 2025). High prevalence of kidney
disorders is the key driving factor.
Dilution &
concentration, imaging, clearance, and urine tests are the major products
within the market. Clearance tests gained over 30% market share in 2016.
Imaging tests on the other hand, may register a high CAGR over the forthcoming
years.
Hospitals dominated the
end-user segment in 2016 on account of sophisticated infrastructure and huge
patient volume. Diagnostic laboratories are expected to exhibit a lucrative
CAGR during the forecast period. Prominent market players include Quest
Diagnostics, Merck Millipore, Randox Laboratories, and Siemens Healthineers.
In-Depth research report on kidney function tests market:
No comments:
Post a Comment